Comorbidities and mortality rate in COVID‐19 patients with hematological malignancies: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Comorbidities and mortality rate in COVID‐19 patients with hematological malignancies: A systematic review and meta‐analysis

Published:2022-04-06 Issue:5 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Naimi Adel¹,Yashmi Ilya²,Jebeleh Reza²^ORCID,Imani Mofrad Mohammad²,Azimian Abhar Shakiba²,Jannesar Yasaman²,Heidary Mohsen¹³^ORCID,Pakzad Reza⁴

Affiliation:

1. Cellular and Molecular Research Center Sabzevar University of Medical Sciences Sabzevar Iran

2. Student Research Committee Sabzevar University of Medical Sciences Sabzevar Iran

3. Department of Laboratory Sciences School of Paramedical Sciences Sabzevar University of Medical Sciences Sabzevar Iran

4. Department of Epidemiology Faculty of Health Ilam University of Medical Sciences Ilam Iran

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24387

Reference83 articles.

1. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies

2. Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis

3. Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies

4. Risk of COVID-19 for patients with cancer

5. Patients with cancer appear more vulnerable to SARS‐CoV‐2: a multicenter study during the COVID‐19 outbreak;Dai M;Cancer Discov,2020

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sotrovimab in Severe COVID-19 anti-S Seronegative Immunocompromised Patients: Multicenter Retrospective Cohort;2024-06-06

2. Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights;Clinical and Experimental Medicine;2024-06-04

3. Clinical characteristics and prognostic factors of COVID-19 infection among cancer patients during the December 2022 – February 2023 Omicron variant outbreak;Frontiers in Medicine;2024-05-30

4. Real‐Life Comparison of Antivirals for SARS‐CoV‐2 Omicron Infection in Patients With Hematologic Malignancies;Influenza and Other Respiratory Viruses;2024-03

5. Characteristics of patients who died in the hospital emergency service during the SARS-CoV-2 pandemic: a retrospective cohort study in a tertiary hospital in Spain;Internal and Emergency Medicine;2024-01-25